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Abstract
Aurora A is an important oncogenic kinase for mitotic spindle assembly and a potentially attractive target for human
cancers. Its activation could be regulated by ATP cycle and its activator TPX2. To understand the activation mechanism of
Aurora A, a series of 20 ns molecular dynamics (MD) simulations were performed on both the wild-type kinase and its
mutants. Analyzing the three dynamic trajectories (Aurora A-ATP, Aurora A-ADP, and Aurora A-ADP-TPX2) at the residue
level, for the first time we find two TPX2-dependent switches, i.e., switch-1 (Lys-143) and switch-2 (Arg-180), which are
tightly associated with Aurora A activation. In the absence of TPX2, Lys-143 exhibits a ‘‘closed’’ state, and becomes
hydrogen-bonded to ADP. Once TPX2 binding occurs, switch-1 is forced to ‘‘open’’ the binding site, thus pulling ADP away
from Aurora A. Without facilitation of TPX2, switch-2 exits in an ‘‘open’’ conformation which accompanies the outward-
flipping movement of P?Thr288 (in an inactive conformation), leading to the crucial phosphothreonine exposed and
accessible for deactivation. However, with the binding of TPX2, switch-2 is forced to undergo a ‘‘closed’’ movement, thus
capturing P?Thr288 into a buried position and locking its active conformation. Analysis of two Aurora A (K143A and R180A)
mutants for the two switches further verifies their functionality and reliability in controlling Aurora activity. Our systems
therefore suggest two switches determining Aurora A activation, which are important for the development of aurora kinase
inhibitors.
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Introduction
Aurora-A, as a member of the Aurora family of serine-threonine
kinases, localizes to centrosomes and proximal mitotic spindles and
regulates spindle-associated events during early mitosis [1]. It
functions mainly in centrosome separation and maturation,
spindle assembly and stability, chromosome condensation, and
cytokinesis in mammalian cells [2,3]. This kinase is overexpressed
in a wide range of tumor types at high frequency compared with
essentially nonproliferating matched normal tissue, which is
associated with amplification of the region of chromosome 20
encoding AURKA [4]. Increased Aurora A expression cause
increased kinase activity, finally contributing to tumor initiation
and progression [5]. This oncogenic role of Aurora A, coupled to
its essential role in mitotic progression, thus make inhibition of
Aurora’s activity become a prominent strategy in the development
of rational cancer therapeutics [6].
The kinase activity of Aurora A is tightly regulated by the ATP
cycle in the ATP binding site [7] that is located at the interface of
catalytic core, comprised of an N-terminal lobe (residues 123–210)
and a large C-terminal lobe (residues 217–387). This region
involves a complex kinetic cycle of ATP binding, nucleotide
hydrolysis, and sequential release of the products Pi and ADP,
respectively [8]. A steady cycle of ATP is so critical that an
inhibitor which blocks certain step of this cycle deactivates the
kinase in seconds [9]. During the process of ATP hydrolysis,
conformational coupling to this step allows functionally important
conformational transitions of a contiguous segment of the C-
terminal domain known as the ‘‘activation segment’’ (residues
274–299) (see Figure S1). The conformational change within the
activation segment involves phosphorylation of a conserved
threonine residue (Thr-295 in Xenopus, Thr-288 in human) [7]
critical for the activity of Aurora A, although it is unclear as to the
regulation mechanism of phosphorylation for the kinase activity.
This autocatalytic activity of Aurora-A is facilitated by several
partner proteins, such as the microtubule-associated protein
TPX2, Ajuba [10], protein phosphatase inhibitor-2 [11], the focal
scaffolding protein HEF1[12], and a newly identified Bora [13].
TPX2 is one of the most efficiently phosphorylated Aurora A
partner proteins. Upon TPX2 binding, the in vitro autopho-
sphorylation activity of Aurora A is increased, and dephosphor-
ylation is prevented [14,15]. The coprecipitation assay for the
interaction of PP1 (protein phosphatase 1) and Aurora A using a
phosphospecific P?Thr-288 antibody shows the band correspond-
ing to protected P?Thr-288 is only found in the present of full
length human TPX2 or TPX2 1–43, which indicates that TPX2
definitely protects residue Thr-288 from dephosphorylation. The
TPX2 fragment binds Aurora-A with two separate stretches [16].
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16757The upstream stretch (residues 7–21) binds to the N-terminal lobe
of Aurora A in a mostly extended conformation. The downstream
stretch (residues 26–43) adopts an a-helical conformation that
interacts with both the helix aC and the activation segment of
Aurora A.
Although the crystal structures of phosphorylated Aurora-A
have been unveiled [16,17], several fundamental questions related
to the regulation of Aurora A activity by TPX2 remain unclear.
An unsolved question is how TPX2 binding is linked to efficient
ATP cycle in Aurora, and how this cycle coupled with the binding
of TPX2 affect the kinase activity.
However, experimental evidence for the dynamics of ATP-,
ADP- and TPX2-bond Aurora A is very hard to obtain. Much of
the experimental information about protein dynamics has come
from superposable crystal structures [15]. Therefore, molecular
dynamics (MD) simulations, as a powerful method to study the
mobility of proteins, is applied in this work to investigate the
mechanism of activation modulation of the Aurora A conforma-
tional dynamics at atomic resolution.
Results and Discussion
1 Switch-1 in the ATP binding site
Since the kinetic cycle of ATP is the essential step to make the
kinase catalytically active [17], inhibition of the ATP cycle can
induce a deactivation process of Aurora A, which makes the ATP
binding site of Aurora-A a novel target for cancer therapy [18].
For Aurora-A, ATP is captured in the ATP binding site
sandwiched between the C- and N-termini. Upon ATP hydrolysis,
a conformational transition of the binding site is triggered by the
binding of TPX2, which facilitates the transfer of phosphate group
and the release of ADP [19]. Although structural and mutational
studies [15,18] have identified several residues involved in Aurora
A activity, it is still unclear which residues do play roles in the
regulation of the ATP cycle, how the residues contact ATP/ADP,
favoring the hydrolysis of ATP and the release of ADP, and
whether these residues cooperate with each other to complete the
cycle process.
To explore the key residues to control the cycle of ATP, we have
performed a total of 20 ns of all-atom MD simulations of three
systems, i.e., Aurora-ATP, Aurora-ADP and Aurora-ADP-TPX2,
in explicit water. Fig. 1.a2 shows that the RMSD of ATP inside
the binding pocket vs. simulation time in the Aurora-ATP system.
Interestingly, the RMSD of ATP remains ,0.5 A ˚ during the first
5.2 ns, and it reaches up to ,0.9 A ˚ and even more in the
following 14.8 ns. Further analysis reveals that ATP switches
between two conformations (upward and downward states) in its
binding site, and the main difference between them lies in the state
of phosphorous side chain (Fig. 1.a1), raising the question of how
Aurora A regulate the conformational switching between the
binding (upward) and the release (downward) states for ATP?
The time evolution of the RMS fluctuation (RMSF) in Fig. 1.a5
shows that the binding of ATP leads to the stability of the ATP
binding site (RMSF =90,100 A ˚) with the exception of residues
141–143 (RMSF =160,320 A ˚) in loop 1–2, indicating that loop
1–2 is extremely flexible. Loop 1–2 can swing up and down
(,2A ˚), as indicated by the black arrow in Fig. 1.A. The
movement of this loop makes Lys-143 on the top of ATP undergo
significant conformational changes in the entire simulation time as
evidenced by its large rotation of angle (CB-CG-CD-CE) from
2180u,180u (Fig. 1.a3). In the first 6.0 ns, a stable hydrogen
bond (H-bond) is formed between Lys-143 (H) and ATP (O1B)
with a H-bond length of ,2.5 A ˚ (Fig. 1.a4). However after 6.0 ns,
the interaction between them is suddenly broken, resulting in a
significant increase of RMSF from 27 to 320 A ˚, and this residue
freely flips up and downward around the vertical plane for the loop
1–2 over 12 ns (Fig. 1.A). Interestingly, at the last 2 ns, Lys-143
rotates downward again (30u) and is weakly H-bounded to ATP
(O1B) with the H-bond length of 3.560.5 A ˚ (Fig. 1.a4). From this
process, we can find that Lys-143 vividly captures the small
molecule ATP in an intermittent manner, which is distinct from its
motion in the Aurora-ADP-TPX2 system (Fig. 1. A). This
formation and disruption of H-bond explains why the phospho-
rous side chain of ATP flip up (H-bond formed) at the beginning
but downward (H-bond broken) in the end. The upward
conformation might indicate the intimate binding of ATP in the
pocket, yet the downward mode might indicate a release trend of
phosphate group from the protein. We thus conclude that Lys-143
constitutes a critical switch governing the binding or even release
of ATP in the binding site.
After ATP hydrolysis, Lys-143 further rotates into the ATP
binding site and exhibits a ‘‘closed’’ conformation. (Fig. 2. B).
Interestingly, in the first 1.6 ns, the backbone hydrogen of Lys-143
(H) generates an H-bond (H-1) with ADP (O1B) (Fig. 2. b1).
However, in the subsequent time, the amino group of this residue
undergoes a dramatic 60u clockwise rotation (Fig. 2. B), resulting
in the disruption of the old H-1 and the simultaneous formation of
a new H-bond (H-2) between the side chain of Lys-143 (HZ2) and
ADP (O1B) (Fig. 2. b1). This finding suggests that Lys-143 can
successfully ‘‘hook’’ the b-phosphate of ADP in this ‘‘closed’’ state
(Fig. 2.B). However, Lys-143 still rotates up- and downward
remarkably (35u) in the following 18.4 ns, leading to intermittent
formation of H-2 in the Aurora-ADP complex (Fig. 2. b1). This
result might imply that Lys-143 acts as a potential driving force to
pull this ADP out of the binding pocket. As ADP release is the last
step to complete kinase activity [20], we thus suggest that the
conformational change of Lys-143 plays an important role in this
dissociation process.
In a contrast with the ‘‘closed’’ state for Lys-143 (switch-1),
TPX2 binding makes this residue project out of the ATP binding
site, in an ‘‘open’’ conformation (see Movie S1). In the ternary
system, the binding of TPX2 initially forces loop 1–2 to undergo
an upward movement (,1A ˚) and open the ATP binding site,
causing Lys143 to rotate with a large fluctuation from 180u to
2180u. However, switch-1 still maintains its stable ‘‘open’’
configuration (,2100u) for about 60% of the simulation time
(see its angle (CG-CB-CA-N) in Fig. 3.c1). In this case, Lys-143
does not form a H-bond with ADP as evidenced by the distance
(,4A ˚) between them (data not shown), showing that ADP
becomes more free when Lys-143 opens the ATP binding site.
Further, compared with Aurora-ADP system, we observe that
triggered by the binding of TPX2, the conformational state of Lys-
143 is shifted more stable in the ternary system, since RMSF of
Lys-143 is 67.24 A ˚ in the ternary complex, whereas is 144.76 in
the binary complex. Such a transition shows a potential
cooperation of Lys-143 and ADP, i.e., Lys-143 can swing ADP
and favor its release from the binding pocket.
Further analysis shows a H-bond network is responsible for the
stable open-state of Lys-143, which is produced between TPX2
and b-sheet 4 close to loop 1-2 and helix aB, including H-bonds of
Tyr-199 (OH) and Tyr-10
TPX2 (H), Tyr-199 (H) and Pro-13
TPX2
(O) (Fig. 3.c2). The binding of TPX2 forces b-sheet 4 to undergo a
translation movement to ATP direction (,0.5 A ˚), definitely
reducing the space between helix aB and b-sheet 4 (Fig. 3.C),
which results in the formation of H-bond between His-201 (ND1)
and Lys-166 (HZ1) (Fig. 3.c2). In this process, helix aB rotates
clockwise (,25u) and approaches more contiguous to loop 1-2
(,1A ˚). As a result, Gln-168 (OE1) in helix aB forms a H-bond
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(,3.5 A ˚) (Fig. 3. c3). This H-bond interaction exerts a constraint
force on loop 1-2, thereby leading to conformational stable Lys-
143. This analysis thus suggests that the stability of secondary
structure in the loop 1–2 that facilitates the swing and open
conformation of Lys-143 is regulated by a considerable concom-
itant consolidation of the TPX2 fragment.
2 Switch-2 in the activation loop
Aurora A kinase activity depends on autophosphorylation of
Thr-288 in the activation loop. TPX2 binding locks the catalytic
domain of the kinase into an active configuration to keep the
phosphorylated Thr-288 into a phosphatase-inaccessible confor-
mation [21]. The X-ray crystal structure has released that the
binding site of TPX2 is more than 20 A ˚ away from P?Thr288,
implying that Aurora A should exhibit certain conformational
transition in its N-terminal lobe upon binding of TPX2, and such
a global alteration in kinase conformation might be associated with
certain allosteric characteristics of the activation loop where
Thr288 is located. However, how does the binding of TPX2
influence P?Thr288? Whether there exist certain actions from
helix aC, which regulates P?Thr288 in an animate (inward) or
catalyzed (outward) state, since the downstream stretch (residues
26–43) of TPX2 directly interacts with the helix aC of Aurora A
[16]?
To address these questions, we compare the motion of the
activation loop and its vicinity over the 20 ns trajectories of
Aurora-ADP and Aurora-ADP-TPX2. The RMSF analysis has
shown that the flexibility of Arg-180 in helix aC significantly
differs in the binary and ternary simulations (94.19 A ˚ for Aurora-
ADP, and 9.28 A ˚ for Aurora-ADP-TPX2), which may indicate
that this residue is functionally associated with Aurora A activity.
Figure 1. Superposition of the ATP binding sites for the typical snapshots of the Aurora–ATP simulation. 4.35 ns and 8.35 ns. For
clarity, only the key region of loop 1–2 is colored in gray (4.35 ns) and blue (8.35 ns). Lys–143 at 4.35 ns is shown in blue line presentation, while
residues and ADP at 8.35 ns are shown in stick presentations: cyan for carbon, white for hydrogen, red for oxygen, and blue for nitrogen atoms. As
indicated by the black arrow, loop1–2 moves upward, accompanied by the formation and disruption of the hydrogen bond (the dashed line)
between Lys–143 (H) and ATP (O1B) in an ‘‘open’’ state. (a1), superposition of ATP focusing on the different conformations of the triphosphate side
chain (upward and downward states). (a2), time–dependence of RMSD of ATP. The dashed line depicts the upward and downward conformations of
ATP. (a3), time–dependent rotation of Lys–143 about the (CB–CG–CD–CE) dihedral angle. (a4), time evolution of the distance between Lys–143 (H)
and ATP (O1B). (a5), time evolution of the RMSF in the Aurora–ATP simulation. The red lines depict residues involved in the ATP binding site: Leu139–
Arg–151, Glu–211–Thr–217 and Arg–255–Gly276. The result of the RMSF analysis indicates that in the binary simulation there are significant
fluctuations centered around residues 141–143 (loop 1–2).
doi:10.1371/journal.pone.0016757.g001
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and transiently oscillates from 2180u to 180u as evidenced by its
dihedral angle (C-CA-CB-CG), and stays at 180u in most of the
simulated time (Fig. 4.d1). On this time scale, Arg-180 exhibits a
relatively stable conformation (180u) and protrudes outside the
ATP binding site in an ‘‘open’’ state (Fig. 4.D). In contrast to the
large fluctuation of Arg-180, the activation segment only under-
goes slightly changes (RMSF=35 A ˚). The slight in-outward
movement of the activation segment leads to small-scale motions
of the phosphate group of P?Thr-288 with its varied dihedral angel
(O2P-P-OG-CB) between 2160u and 170u. Thus this residue can
orient it in the outward direction so as to permit the accession of
phosphatase such as PP1, with a consequence of loss of the
phosphate group from this amino acid [19]. Given the ‘‘open’’
states of both Arg-180 and P?Thr-288 in the binary complex,
clearly no H-bond is formed between them as their inter-residue
distance is ,12 A ˚ (Fig. 4.d4). However, once TPX2 binds to
Aurora A, Arg-180 rotates downward (40u) and becomes a rigid,
‘‘closed’’ state (RMSF =9.28 A ˚) (Fig. 4.D). Meanwhile, the
activation loop also significantly rotates inward to ATP (3 A ˚), thus
maintaining P?Thr-288 in an active conformation in the ternary
complex (Fig. 4.D). In this ‘‘closed’’ state, a stable H-bond is
formed between Arg-180 and P?Thr-288 and the H-bond length
keeps 2.1 A ˚ in Fig. 4.d4.
We further find that the conformational transitions of Arg-180
and P?Thr-288 are respectively induced by two independent H-
bond networks, i.e., 1) the upstream of TPX2 vs Helix aC
(network-1); 2) the down stream of TPX2 vs activation loop
(network-2). Network-1 includes H-bonds of Glu-175 (OE2) and
Ser-7
TPX2 (H3), Arg-179 (H) and Tyr-10
TPX2 (OH), Glu-183
(OE2) and Asp-11
TPX2 (H), and Arg-179 (HH21) and Glu-183
(OE2) (Fig. 4.d3). This network strengthens the contact between
TPX2 and helix aC, which stabilizes this helix and also forces it to
slightly descend by 0.3 A ˚, thereby causing a strong H-bond (2 A ˚)
between Arg-180 and P?Thr-288 (Fig. 4. d3). And network-2 is
composed of Ser-284 (HG) and Asn-43
TPX2 (O), Ser-284 (HG)
and Asn-43
TPX2 (OXT), Arg-286 (HH12) and Glu-42
TPX2 (OE2),
as well as Thr-288 (O3P) and Arg-286 (HH21) (Fig. 4.d4). The
network-2 makes the activation loop to rotate in a buried
conformation as indicated by the black arrow in Fig. 4.D. The
motion of this loop subsequently causes P?Thr-288 to flip inward
by 100u from its outward state. Combined, the two networks
triggered by the binding of TPX2 favors the inward flip of
P?Thr-288.
3 Cross-correlation of the two switches
As the residues involved in the switch-1 (Lys-143) and switch-2
(Arg-180) are structurally neighboring, we suppose that they might
also functionally cooperate with each other. The dynamic cross-
correlation map (DCCM) is then used to further investigate the
correlations of switch-1 and switch-2. DCCM describes the global
correlated motions among residues from the highly anticorrelated
(blue) to the highly correlated (red).
Fig. 5 shows that the fluctuations of Lys-143 and ADP are, on
the average, positively correlated in both the binary and ternary
systems. Interestingly, the TXP2 binding does not increase the
correlation between the two residues with the correlation
coefficient (R=0.9) same as the binary simulation of 0.9. Similarly,
strong positive correlations are also observed between Arg-180 and
P?Thr-288 in the two systems, however, the R arises to 0.97
(ternary) from 0.83 (binary) due to TXP2 binding. In addition, we
also find strong correlations between switch-1 and switch-2, with a
correlation of R=0.74 in the binary system, while 0.82 in the
ternary system, meaning that inter-switch cooperation is also
enhanced upon TPX2 binding.
4 Mutations of switch-1 and switch-2
To further map the functionality of the two switches, an
additional MD simulation on K143A and R180A mutants is
performed. Comparing K143A with the wild type Aurora A, the
hydrogen bond interaction between the b-phosphate group of
ADP and the backbone amino group of K143A is formed and lasts
1.5 ns due to the increased side chain fluctuation of K143A
(RMSF is 158.44 A ˚ for the mutant protein, and is 67.24 for the
wild type protein). The formation of the hydrogen bond between
ADP and K143A delays the release of ATP, resulting in the
interruption of normal ATP cycle. Therefore, the evidence from
the mutant ternary system demonstrates the function of swich 1
from another respect.
While for the mutation of Arg-180 to Ala in Aurora A, this
mutation actually interrupts the hydrogen bond interaction
between Arg-180 and P?Thr-288 in the wild-type Aurora A,
leading to the outward flip of P?Thr-288 in the activation loop
(see Fig. S2). This is evidenced by the time evolution of the
distance (10 A ˚) between the phosphate group of Thr-288 and the
backbone hydrogen of R180A, resulting in the stable open state
of P?Thr-288 (Fig. S2). We thus reason that mutation of the two
residues to other amino acids with short side chains might
Figure 2. Superposition of the ATP binding sites for the typical
snapshots of the Aurora–ADP simulation. 1.0 ns and 5.0 ns. For
clarity, the key residue Lys–143 is shown in red line at 1.0 ns, while in
sticks at 5.0 ns (cyan, carbon atoms; white, hydrogen atoms; blue,
nitrogen atoms and red, oxygen atoms). After the first 1.6 ns, the
hydrogen bond between Lys–143 (H) and ATP (O1B) is broken, but
instead, the amino side chain of Lys–143 (HZ2) rotates to be contiguous
to ATP, thus forming a new hydrogen bond (the dashed line) with the
small molecular (O2B) in a ‘‘closed’’ state. The movement of Lys–143 is
indicated by using the arrow. (b1), time evolutions of the distance
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lation of Aurora A, therefore blocking activation of the
protein.
Conclusions
The kinase Aurora A is overexpressed in many tumors, and
has become an effective target for anticancer drug. There are
two routes to inhibiting its function: 1) interfere with its ability
to interact with its binding partners, such as TPX2; 2) occupy
the catalytic ATP binding site. Targeting protein–protein
interactions with small-molecule inhibitors and selectively
targeting the enzymatic activity of kinase with small molecules
have proved to be great challenges since the key residues
involved in the regulating of ATP cycle and TPX2 binding are
still not unveiled. In this study, we present two functional
correlated TPX2-dependent switches important for Aurora A
activation, which have not been investigated so far. Swith-1
composed of Lys-143 plays an essential role in kinetic cycle of
ATP binding, nucleotide hydrolysis, and release of ADP, thus
regulating the activity of Aurora A. Switch-2 includes Arg-180,
the open and closed states of which restricts the conformational
movement of P?Thr-288, thus completing the cell cycle-
dependent feedback of phosphorylation/dephosphorylation of
Aurora A. Our in-depth study have uncovered that the
molecular basis of Aurora A activation is largely determined
by the two novel switches, which is important in designing the
compounds for treating tumors.
Methods
1 Structural preparation
Initial coordinate of Aurora A was taken from the human X-ray
crystal structure [15] (PDB entries 1ol5, 1ol6 and 1ol7). Molecular
dynamics (MD) simulations in explicit water have been indepen-
dently carried out on a simulation time scale of 20 ns for (1) the
unbound apo form of the Aurora A in solution (apo-Aurora), (2)
Aurora A complexes with the natural substrate ATP (Aurora-
ATP), (3) Aurora A complexes with the substrate ADP (Aurora-
ADP), (4) Aurora A-ADP complexes with the coactivator TPX2
(Aurora-ADP-TPX2) and (5) Aurora-ADP-TPX2 with the K143A
and R180A mutants. The missing residues (Leu22-Gln29 of the
TPX2 segment (1ol5), and Gly142, Gly173 and Val174 of Aurora
A (1ol6)) were repaired by using the loop search method in the
Swiss-PdbViewer (aka DeepView, http://spdbv.vital-it.ch/). After
removal of the phosphate group from the phosphorylated Thr287,
the crystal structure of Aurora A in complex with ADP and TPX2
(1ol5), was used directly in the simulation of Aurora-ADP-TPX2
complex, and was also applied to generate the starting structure of
the Lys143-Ala and Arg180-Ala mutants. This Ala was selected for
the reason that no H-bond could be formed in the mutants for this
residue. By analyzing the Lys143Ala and Arg180Ala trajectory, we
observed that the mutated Aurora A could retain the basic native
structure. Similarly, the simulations of Aurora-ATP and Aurora-
ADP complexes were respectively generated from the crystal
structures 1ol6 and 1ol7. In the absence of crystal structure of apo-
Figure 3. Superposition of the average structures of the Aurora–ADP (brown) and the Aurora–ADP–TPX2 (cyan) simulations.
Residues in the binary structure are shown in brown line presentation, while residues in the ternary complex and ADP are shown in stick
presentations: cyan for carbon, white for hydrogen, red for oxygen, and blue for nitrogen atoms. The TPX2 fragment is displayed in the gray ribbon.
The position of the binding region among helix aB, b–sheet 4 and the upstream of TPX2 is circled in dashed lines. After TPX2 binding, Tyr–199
respectively forms a H–bonds with Tyr–10
TPX2 (H) and Pro–13
TPX2(O) (the dashed lines) to pull b–sheet 4 to be more contiguous to helix aB. Due to
the decreased distance between b–sheet 4 and helix aB, His–201 (ND1) interacts with Lys–166 (HZ1) to force helix aB to undergo a rotation
movement (,1A ˚). This process causes the formation of a H–bond between Gln–168 (OE1) in helix aB and Gly–145 (H) in loop 1–2. As a result, the
constrained loop 1–2 leads to a stable, ‘‘open’’ state of Lys–143. (c1), time–dependent rotation of Lys–143 about the (CG–CB–CA–N) dihedral angle in
the ternary simulation. (c2), the view is rotated 90u about the y axis relative to (C). (c3), time evolutions of the distance between Lys–166 (HZ1) and
His–201 (ND1), Gln–168 and Gly–145 (H), Tyr–199 (OH) and Tyr–10
TPX2 (H), and Tyr–199 (H) and Pro–13
TPX2 (O) in the ternary simulation.
doi:10.1371/journal.pone.0016757.g003
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structure of Aurora A in complex with ADP and TPX2 (1ol5) by
removing the ligand and TPX2 from the active site and the
phosphate groups of phosphorylated Thr287 and Thr288.
The Amber03 force field [22] was used with xLeap in Amber10
[23] for system setup, and AMBER force parameters for ATP,
ADP [24] and Thr with unprotonated phosphate group [25] were
derived from AMBER parameter database (www.pharmacy.
manchester.ac.uk/bryce/amber). A box of TIP3P water molecules
[26] that extended at least 12.0 A ˚ outside the protein was added to
solvate to each system (74.98 A ˚690.58 A ˚690.20 A ˚ for apo-
Aurora, 73.10 A ˚668.40 A ˚675.76 A ˚ for Aurora-ATP, 78.38 A ˚6
Figure 4. Superposition of the average structures of the Aurora–ADP (brown) and the Aurora–ADP–TPX2 (cyan) systems. Residues in
the binary structure are shown in brown stick presentation, while residues in the ternary complex are shown in colored stick presentations: cyan for
carbon, white for hydrogen, red for oxygen, and blue for nitrogen atoms. ADP is displayed in the red line. Upon the binding of TPX2, Arg–180 (HH12)
forms a hydrogen bond with P?Thr–288 (O2P) to pull the latter residue in an inward conformation. The movement of P?Thr–288 is indicated by using
an arrow. (d1), time–dependent rotation of Arg–180 about the (C–CA–CB–CG) dihedral angle in the binary simulation. (d2), side view of the binding
region between helix aC and the upstream of TPX2. The Aurora A and the TPX2 fragment are respectively colored cyan and gray. The first H–bond
network is formed between Glu–175 (OE2) and Ser–7
TPX2 (H3), Arg–179 (H) and Tyr–10
TPX2 (OH), Glu–183 (OE2) and Asp–11
TPX2 (H), and Arg–179
(HH21) and Glu–183 (OE2) (the dashed lines), thus constraining the fluctuation of Arg–180. The second hydrogen bond network is formed between
Ser–284 (HG) and Asn–43
TPX2 (O), Ser–284 (HG) and Asn–43
TPX2 (OXT), Arg–286 (HH12) and Glu–42
TPX2 (OE2), and Thr–288 (O3P) and Arg–286 (HH21)
(the dashed lines), thus constraining the fluctuation of Thr–288. (d3), time evolutions of the distance between Arg–180 and P?Thr–288 in the binary
and the ternary simulations. (d4), time evolutions of the distance between Glu–175 and Ser–7
TPX2, Arg–179 and Tyr–10
TPX2, Glu–183 and Asp–11
TPX2,
Arg–179 and Glu–183, and Arg–251 and Glu–37
TPX2 in the ternary simulation. (d5). time evolutions of the distance between Ser–284 and Asn–43
TPX2,
Ser–284 and Asn–43
TPX2, Arg–286 and Glu–42
TPX2, and Thr–288 and Arg–286 in the ternary simulation.
doi:10.1371/journal.pone.0016757.g004
Figure 5. Cross correlation matrices of fluctuations of Aurora A atoms from their average values during the last 10 ns of the binary
(e1) and ternary (e2) simulations.
doi:10.1371/journal.pone.0016757.g005
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for Aurora- ADP-TPX2, and 73.60 A ˚673.96 A ˚669.47 A ˚ for
mutant Aurora-ADP-TPX2). To neutralize the system, Na
+ and
Cl
2 counter ions were added. Ions were placed on the basis of the
electrostatic energy of the water oxygens. Finally, the five systems
were minimized respectively, usually for 5000 steepest-descent
steps followed by 5000 conjugate-gradient steps.
2 Simulation Protocol
All simulations were run by the sander module in Amber 10
[25]. MD simulations started with heating the system from 0 to
300 K in 100 ps followed by a 50 ps pressure-constant period to
raise the density while still keeping the complex atoms constrained,
after which 0.5 ns of equilibration was conducted. The following
20 ns were considered as further equilibration time and analysis
was done on the following parts of trajectories. Finally, the
production phase was run for 20 ns, considering that each
trajectory is long enough to ensure sufficient sampling of the
protein’s configuration space and the ligand, i.e., allowing the
systems to cross the barrier between folded and misfolded free
energy basins more than once. MD simulations were run in the
NPT ensemble, using periodic boundary conditions, a 2 fs
timestep, and SHAKE algorithm [27] to constrain all bonds to
hydrogens. The temperature was kept at 300 K using Langevin
dynamics [28] with a collision frequency of 1 ps
21. The cutoff
distance was kept to 8 A ˚ to compute the nonbonded interactions.
All the simulations were performed under periodic boundary
conditions, and long-range electrostatics was treated by using the
particle-mesh-Ewald (PME) method [29]. Snapshots were col-
lected from the stable structures during the last 10 ns of the four
simulations for analysis (1snapshot/10 ps).
Supporting Information
Figure S1 Ribbon diagram of the Aurora A structure
(cyan) oriented to show the relative positions of the C-
and N-terminal lobes. TPX2 is colored in red ribbon, and
ADP and Thr-288 are shown in blue sticks.
(tif)
Figure S2 The average structure of the mutant Aurora-
ADP-TPX2 (cyan) simulation. Residues and ADP in the
ternary structure are shown in stick presentation: cyan for carbon,
white for hydrogen, red for oxygen, and blue for nitrogen atoms.
TPX2 is displayed in the gray ribbon. The dashed lines show the
distance between K143A (H) and ADP (O1B), and between
R180A (H) and Thr288 (O2P). (a) the time evolution of distance
between K143A (H) and ADP (O1B), and between R180A (H) and
Thr288 (O2P) in the ternary simulation.
(tif)
Movie S1 The open and closed motions of switch-1 (Lys-
143) and switch-2 (Arg-180) in the Aurora A-ATP, Aurora
A-ADP, and Aurora A-ADP-TPX2 simulations. Aurora A is
shown in gray ribbon, Lys-143 and ATP/ADP are shown in stick
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